Results 111 to 120 of about 12,661 (240)
Targeted Epigenetic Activation of CTLA4 in Haploinsufficiency Cellular Models by CRISPRa
Background/Objectives: CTLA4 (Cytotoxic T-Lymphocyte Antigen 4) is a key immune checkpoint that plays a principal part in controlling T-cell activation and maintaining immune homeostasis.
Ekaterina Griazeva +9 more
doaj +1 more source
Successful Treatment of T Cell-Mediated Acute Rejection with Delayed CTLA4-Ig in Mice
Clinical observations that kidney transplant recipients receiving belatacept who experienced T cell-mediated acute rejection can be successfully treated and subsequently maintained on belatacept-based immunosuppression suggest that belatacept is able to ...
James S. Young +8 more
doaj +1 more source
Background: CTLA4, an immune checkpoint, plays an important role in tumor immunotherapy. The purpose of this study was to develop a pathomics signature to evaluate CTLA4 expression and predict clinical outcomes in clear cell renal cell carcinoma (ccRCC ...
Xiaoqun Yang +5 more
doaj +1 more source
Polymorphisms in the CTLA4 promoter sequence are associated with canine hypoadrenocorticism
Background Canine hypoadrenocorticism is an immune-mediated endocrinopathy that shares both clinical and pathophysiological similarities with Addison’s disease in humans. Several dog breeds are overrepresented in the disease population, suggesting that a
Alisdair M. Boag +5 more
doaj +1 more source
LINC00877 is a potential prognostic biomarker with functional significance in prostate cancer
LINC00877 is identified as a prognostic biomarker in prostate cancer, with low expression linked to worse survival and immune infiltration. Knockdown experiments further demonstrate that LINC00877 suppresses invasion and cell cycle progression. Abstract To analyze the expression and clinical significance of LINC00877 in prostate cancer based on The ...
Chen Zhu +4 more
wiley +1 more source
ABSTRACT The antitumor efficacy of an intratumoral injection of a genetically engineered oncolytic vaccinia virus carrying human IL‐7 and murine IL‐12 genes (hIL‐7/mIL‐12‐VV) was demonstrated in CT26.WT‐bearing mice. In the CT26.WT‐bearing mouse model, the efficacy of the combination of hIL‐7/mIL‐12‐VV plus the anti‐programmed cell death protein (PD)‐1
Akihiro Yamada +13 more
wiley +1 more source
A proposed mechanistic framework of systemic lupus erythematosus (SLE) and autoimmune thyroid disease (AITD) pathogenesis. In Stage 1, genetically susceptible individuals harbor risk variants within major histocompatibility complex (HLA) and non‐HLA loci that impair central and peripheral immune tolerance mechanisms within the thymic and peripheral ...
Elisa Elisa +3 more
wiley +1 more source
Purpose: Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) has consistently demonstrated clinical efficacy in metastatic melanoma.
M. Forget +46 more
semanticscholar +1 more source
Nonthermal ultrasound transforms acoustic energy into diverse therapeutic bioeffects through cavitation, mechanical stimulation, and physicochemical activation. This review discusses how acoustic parameters, biological mechanisms, and responsive materials interact to influence nonthermal ultrasound‐enabled cancer therapies. Mechanism‐guided engineering
Liu Wang +5 more
wiley +1 more source
BackgroundIpilimumab is a licensed immunotherapy for metastatic melanoma patients and, in the US, as adjuvant treatment for high risk melanoma radically resected.
S. Valpione +6 more
semanticscholar +1 more source

